← Back to headlines
US FDA Approves Eli Lilly's Mounjaro for Cardiovascular Risk Reduction
The US Food and Drug Administration has approved Eli Lilly's diabetes drug Mounjaro to reduce cardiovascular risk, expanding its approved therapeutic uses beyond blood sugar management.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
